ShinyHunters hit medial giant Abbott, disrupting cancer drug research and more
THE SO WHAT
Ransomware that halts cancer drug research is a reminder that IP and lab uptime are now frontline cyber targets. If you run R&D or clinical ops, treat data integrity and lab system isolation as core program risks, not IT hygiene.
READ THE SOURCE
MORE FROM THE WIRE
Deep & Emerging TechSouth Korea’s Early Exports Jump to July Record on AI-Led Gains
AI-driven semiconductor demand is now moving national export numbers—South Korea’s July record is a macro tell, not just a sector blip. If your roadmap depends on advanced chips, treat supply and pricing as geopolitical variables and lock in multi-year commitments where you can.
Deep & Emerging TechCQE-led Bloch Quantum Tech Hub Raises $55 Million
A $55 million federal‑backed hub for quantum manufacturing in the Illinois‑Wisconsin‑Indiana corridor is a bet that supply chain — not just algorithms — will be the choke point. Hardware and advanced manufacturing teams should start mapping where quantum components might intersect their own vendor networks over the next 5–10 years.
Deep & Emerging TechBlackRock’s Meta Deal to Show the Power of $25 Billion M&A Spree
A $12B+ Meta data center financing is another proof point that AI infra is now a core private-markets asset class. Operators planning large builds should assume more structured capital is available — but also more sophisticated scrutiny on utilization and offtake.
Deep & Emerging TechLumentum’s stock just got a lot more interesting — and Barclays has turned bullish
A bullish turn on an optical player after underperformance suggests investors are rotating within the chip stack, not abandoning it. If you depend on photonics or optical components, expect capital — and vendor focus — to flow back into your part of the supply chain.